Edesa Biotech (NASDAQ:EDSA) is a biopharmaceutical company focused on inflammatory and immune-related diseases. Their operations span the development and commercialization of innovative therapeutics aimed at treating conditions that lack effective treatments. With a keen eye on advancing its research and development, Edesa Biotech's projects include working on novel therapies for dermatological diseases, gastrointestinal disorders, and other acute inflammatory conditions. The company is steadfast in its objective to bring breakthrough solutions to patients, aiming to address the unmet medical needs through its pipeline of potential treatments. By leveraging cutting-edge science and a passion for healing, Edesa Biotech is dedicated to improving patient outcomes and transforming lives through innovation.